- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Daewon Pharm (003220)
Assess today's live Daewon Pharm (003220) share price, performance and insights using our live Seoul: 003220 stock exchange data.
Analyse the historical data and Daewon Pharm share price performance charts on this page. Our technical summary section provides analysis on Daewon Pharm share price buy/sell indicators using real-time data (or discuss the Daewon Pharm (003220) stock price today with other investors in the Daewon Pharm KS share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current KS 003220 share price (ISIN: KR7003220001) to enhance your trading decisions with our free investment tools and resources.
What Is the Daewon Pharm Share Price Today?
The Daewon Pharm share price today is 11,740.
What Is the Stock Symbol for Daewon Pharm
The stock symbol (or 'ticker') for Daewon Pharm is "003220."
What Stock Exchange Does Daewon Pharm Trade On?
Daewon Pharm is listed and trades on the Seoul stock exchange.
Is Daewon Pharm a Good Stock to Buy?
Determining whether Daewon Pharm—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Daewon Pharm share price performance charts on this page. Our technical summary section provides analysis on Daewon Pharm share price buy/sell indicators using real-time data (or discuss the Daewon Pharm (003220) stock price today with other investors in the Daewon Pharm KS share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current KS 003220 share price (ISIN: KR7003220001) to enhance your trading decisions with our free investment tools and resources.
What Is the Daewon Pharm Share Price Today?
The Daewon Pharm share price today is 11,740.
What Is the Stock Symbol for Daewon Pharm
The stock symbol (or 'ticker') for Daewon Pharm is "003220."
What Stock Exchange Does Daewon Pharm Trade On?
Daewon Pharm is listed and trades on the Seoul stock exchange.
Is Daewon Pharm a Good Stock to Buy?
Determining whether Daewon Pharm—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Seoul
Currency in KRW
11,740
+170(+1.47%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
11,590
11,850
52 wk Range
11,220
15,350
003220 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
11,59011,850
52 wk Range
11,22015,350
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
003220 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Strong Buy
Price Target
15,333
Upside
+30.61%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock generally trades with low price volatility
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Daewon Pharm Company Profile
Daewon Pharmaceutical Co., Ltd., a pharmaceutical company, manufactures and sells medicines and medical supplies in South Korea. It offers various medicines for circulatory, respiratory, antibiotic, chemotherapy, and psychoneurosis use. The company’s principal products include Oramin-F Soft Cap, a multivitamin product; Pelubi Tablet, a NSAID product for pain relief; Freefol-MCT Inj., a microemulsion propofol for the anti-exogenous infectious bacteria; Megex-I Susp, a medicine that supplements subalimentation of cancer patients; Trigel Susp, a therapy for gastritis and duodenal ulcer; and Renamezin Cap, a spherical carbonaceous adsorbent for chronic kidney disease. It also exports its products to approximately 40 countries primarily in Asia, Central and South America, the Middle East, CIS, and Africa. The company was founded in 1958 and is headquartered in Seoul, South Korea.
Compare 003220 to Peers and Sector
Metrics to compare | 003220 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship003220PeersSector | |
|---|---|---|---|---|
P/E Ratio | −16.9x | 11.9x | −0.6x | |
PEG Ratio | 0.09 | −0.24 | 0.00 | |
Price/Book | 1.0x | 0.8x | 2.6x | |
Price / LTM Sales | 0.4x | 0.6x | 3.4x | |
Upside (Analyst Target) | 27.9% | 29.9% | 41.8% | |
Fair Value Upside | Unlock | 9.1% | 4.8% | Unlock |
Analyst Ratings
3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 15,333
(+30.61% Upside)
Earnings
Latest Release
Nov 14, 2025
EPS / Forecast
-812.96 / --
Revenue / Forecast
143.90B / 168.35B
People Also Watch
FAQ
What Is the Daewon Pharm (003220) Share Price Today?
The live Daewon Pharm share price today is 11,740
What Stock Exchange Does Daewon Pharm (003220) Trade On?
Daewon Pharm is listed and trades on the Seoul Stock Exchange.
What Is the Ticker (Stock Symbol) for Daewon Pharm?
The stock symbol (also called a 'ticker') for Daewon Pharm is "003220."
What Is the Current Daewon Pharm Market Cap?
As of today, Daewon Pharm market capitalisation is 251.63B.
What Is Daewon Pharm's (003220) Earnings Per Share (TTM)?
The Daewon Pharm EPS is currently -690.75 (Trailing Twelve Months).
When Is the Next Daewon Pharm Earnings Date?
Daewon Pharm's next earnings report will be released on 13 Mar 2026.
Is 003220 a Buy or Sell From a Technical Analyst Perspective?
Based on today's Daewon Pharm moving averages and other technical indicators, the daily buy/sell signal is Buy.
How Many Times Has Daewon Pharm Stock Split?
Daewon Pharm has split 17 times. (See the 003220 stock split history page for full effective split date and price information.)
How Many Employees Does Daewon Pharm Have?
Daewon Pharm has 1283 employees.
What is the current trading status of Daewon Pharm (003220)?
As of 26 Jan 2026, Daewon Pharm (003220) is trading at a price of 11,740, with a previous close of 11,570. The stock has fluctuated within a day range of 11,590 to 11,850, while its 52-week range spans from 11,220 to 15,350.
What Is Daewon Pharm (003220) Price Target According to Analysts?
The average 12-month price target for Daewon Pharm is KRW15,333, with a high estimate of KRW16000 and a low estimate of KRW15000. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +30.61% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.